High-yield automated synthesis of [18F]fluoroazomycin arabinoside ([18F]FAZA) for hypoxia-specific tumor imaging

Applied Radiation and Isotopes

Volumn 69, Issue 7, 2011, Pages 1007-1013

  Hayashi, Kazutaka ^a,b   Furutsuka, Kenji ^a,c   Takei, Makot ^a,d   Muto, Masatoshi ^a,d   Nakao, Ryuji ^a   Aki, Hatsumi ^e   Suzuki, Kazutoshi ^a   Fukumura, Toshimitsu ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b RIKEN   (Japan)

^c Japan   (Japan)

^d Department of Engineering and Environment   (Japan)

^e FUKUOKA UNIVERSITY   (Japan)

Author keywords

18F FAZA; 18F fluoride; Automated synthesis; Hypoxia

Indexed keywords

[18F] FLUORIDE; [18F]FAZA; AUTOMATED SYNTHESIS; CLINICAL USE; HYPOXIA; RADIOCHEMICAL YIELD; ROOM TEMPERATURE; TUMOR IMAGING;

HYDROLYSIS; PROJECTILES; RESINS;

AUTOMATION;

DIMETHYL SULFOXIDE; FLUOROAZOMYCIN ARABINOSIDE F 18; SODIUM HYDROXIDE; TRACER; UNCLASSIFIED DRUG;

ARTICLE; AUTOMATION; CONTROLLED STUDY; DRUG SYNTHESIS; ELUTION; HYDROLYSIS; PRIORITY JOURNAL; RADIOCHEMISTRY; RADIOISOTOPE DECAY;

AUTOMATION; CELL HYPOXIA; FLUORINE RADIOISOTOPES; HUMANS; NEOPLASMS; NITROIMIDAZOLES;

EID: 79955640331     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2011.02.025     Document Type: Article

References (20)

1. Chapman J.D. Hypoxic sensitizers: implication for radiation therapy. N. Engl. J. Med. 1979, 301:1429-1432.
2. Dolbier W.R., Li A.-R., Koch C.J., Shiue C.-Y., Kachur A.V. [18F]-EF5, a marker for PET detection of hypoxia: synthesis of precursor and a new fluorination procedure. Appl. Radiat. Isot. 2001, 54:73-80.
3. Eschmann S.M., Paulsen F., Reimold M., Dittmann H., Welz S., Reischl G., Machulla H.J., Bares R. Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. J. Nucl. Med. 2005, 46:253-260.
4. Eschmann S.M., Paulsen F., Bedeshem C., Machulla H.J., Hehr T., Bamberg M., Bares R. Hypoxia-imaging with 18F-Misonidazole and PET: changes of kinetics during radiotherapy of head-and-neck cancer. Radiother. Oncol. 2007, 83:406-410.
5. Gronroos T., Eskila O., Lehtio K., Minn H., Marjamaki P., Bergman J., Haaparanta M., Forsback S., Solin O. Pharmacokinetics of [18F]FETNIM: a potential maker for PET. J. Nucl. Med. 2001, 42:1397-1404.
6. Hamacher K., Blessing G., Nebeling B. Computer aided synthesis of no carrier added 2-[18F]fluoro-2-d-glucose: an efficient automated system for the aminopolyether-supported nucleophilic fluorination. Appl. Radiat. Isot. 1990, 41:49-55.
7. Ishikawa Y., Iwata R., Furumoto S., Takai Y. Automated preparation of hypoxic cell maker [18F]FRP-170 by on-column hydrolysis. Appl. Radiat. Isot. 2005, 62:705-710.
8. Kumar P., Wiebe L.I., Asikoglu M., Tandon M., McEwan A.J. Microwave-assisted (radio)halogenation of nitroimidazole-based hypoxia markers. Appl. Radiat. Isot. 2002, 57:697-703.
9. Nakao R., Ito T., Hayashi K., Fukumura T., Suzuki K. Ultrafast LC method for purification and metabolite analysis of PET probes. Nucl. Med. Biol. 2010, 37:67-72.
10. Nandy S.K., Rajan M.G.R. Simple, column purification technique for fully automated radiosynthesis of [18F]fluoroazomycinarabinoside ([18F]FAZA). Appl. Radiat. Isot. 2010, 68:1944-1949.
11. Oh S.J., Chi D.Y., Mosdzianowski C., Kim J.Y., Gil H.S., Kang S.H., Ryu J.S., Moon D.H. Fully automated of [18F]fluoromisonidazole using a conventional [18F]FDG module. Nucl. Med. Biol. 2005, 32:899-905.
12. Piert M., Machulla H.J., Picchio M., Reischl G., Ziegler S., Kumar P., Wester H.J., Beck R., McEwan A.J., Wiebe L.I., Schwaiger M. Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside. J. Nucl. Med. 2005, 46:106-113.
13. Postema E.J., McEwan A.J.B., Riauka T.A., Kumar P., Richmond D.A., Abrams D.N., Wiebe L.I. Initial results of hypoxia imaging using 1-α-d-(5-deoxy-5-[18F]-fluoroarabinofuranosyl)-2-nitroimidazole ([18F]FAZA). Eur. J. Nucl. Med. Mol. Imaging 2009, 36:1565-1573.
14. Rasey J.S., Koh W.J., Evans M.L., Peterson L.M., Lewellen T.K., Graham M.M., Krohn K.A. Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients. Int. J. Radiat. Oncol. Biol. Phys. 1996, 24:417-428.
15. Reischl G., Ehrlichmann W., Bieg C., Solbach C., Kumar P. Preparation of the hypoxia imaging PET tracer [18F]FAZA: reaction parameters and automation. Appl. Radiat. Isot. 2005, 62:897-901.
16. Reischl G., Dorow D.S., Cullinane C., Katsifis A., Roselt P., Binns D., Hicks R.J. Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA-first small animal PET results. J. Pharm. Pharm. Sci. 2007, 10:203-211.
17. Schlyer D.J., Bastos M.A.V., Alexoff D., Wolf A.P. Separation of [18F]fluoride from [18O]water using anion exchange resin. Appl. Radiat. Isot. 1990, 41:531-533.
18. Suehiro M., Vallabhajosula S., Goldsmith S.J., Ballon D.J. Investigation of the role of the base in the synthesis of [18F]FLT. Appl. Radiat. Isot. 2007, 65:1350-1358.
19. Sorger D., Patt M., Kumar P., Wiebe L.I., Barthel H., Seese A., Dannenberg C., Tannapfel A., Kluge R., Sabri O. [18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors. Nucl. Med. Biol. 2003, 30:317-326.
20. Tewson T.J. Synthesis of [18F]fluoroetanidazole: a potential new tracer for imaging hypoxia. Nucl. Med. Biol. 1997, 24:755-760.